You’ve done the diligence. The clinical need is real. The team is strong. The technology works. So why isn’t the product moving?

For healthtech investors, this scenario is frustratingly familiar. A promising portfolio company clears every early hurdle, regulatory, clinical, commercial, only to stall at provider adoption. The solution sits inside a portal no one visits, or behind a workflow no one has time to navigate. Providers don’t abandon it because the product is bad. They abandon it because it asks them to change how they work.

Provider adoption is fundamentally an integration problem. And the smartest investors in healthtech are getting ahead of it.

Why Provider Adoption Is a Portfolio-Level Risk

Provider adoption is a systemic risk that plays out across portfolios, particularly in referral management, care coordination, and specialty care solutions that depend on physician-initiated workflows.

The math is simple: if providers aren’t referring, the network doesn’t grow. If the network doesn’t grow, the unit economics don’t work. And if the unit economics don’t work, the next fundraise becomes a much harder conversation.

Most healthtech companies underestimate how much friction exists between “product is ready” and “provider is using it.” Faxes are still standard in many health systems. Portals require an average of 25 clicks to send a referral. Traditional EHR integrations take six months or more and still don’t fit how providers actually work.

Every one of those friction points is a place where adoption dies.

The Insight That Changes the Equation

The healthtech companies that break through the adoption barrier share a common insight: providers don’t change their workflow for new solutions. The solution has to enter the provider’s existing workflow.

That means the product needs to live inside the EHR, surfaced at the moment a clinical decision is being made, pre-populated with patient data, with the ability to complete in seconds. Most vendors build their product first and treat EHR integration as an afterthought. The companies that get adoption right invert that sequence entirely.

What Forward-Thinking VCs Are Doing Differently

The most sophisticated healthtech investors are treating EHR integration as a commercial prerequisite, something addressed before a company goes to market, not after growth stalls. In practice, that means asking harder questions during diligence:

• Can the solution surface directly inside the EHR, at the point of care?
• How much IT lift does integration require from health system partners?
• Is it scalable across different EHR environments, or does each new system require a custom build?

These are commercial questions that determine whether a product achieves meaningful adoption or gets stuck in pilot purgatory. VCs who recognize this are also bringing EHR enablement infrastructure to their portfolio companies as a strategic resource, rather than leaving each company to solve it independently.

Where Arrowhealth Fits in the Portfolio Strategy

Arrowhealth gives healthtech companies the infrastructure to embed their solutions directly into provider EHR workflows, without custom point-to-point integrations for every health system.

Bridge connects solutions to 36+ mapped EHRs with full white-labeling, Single Sign-On, and custom UI options. The Bridge SDK lets development teams inject their existing platform directly into the EHR, compressing implementation timelines that traditionally stretch six months or more. See how SaRA Health used Bridge to accelerate adoption and reduce implementation time in the SaRA Health case study.

Built on top of Bridge, Navigator delivers a portfolio company’s full platform experience directly within the provider’s EHR workflow, using context-aware alerts and Single Sign-On logic so providers never have to leave the EHR to access it.

Together, they close the distance between where providers work and where healthtech companies ask them to go.

The Compounding Effect on Portfolio Value

When EHR integration is done right, the impact compounds. Provider adoption accelerates. Referral volume increases. New health system partners come online faster. And companies that live inside the provider’s daily workflow are harder to displace. When a solution becomes part of how providers work every day, they’re far less likely to abandon it for a competitor.

The Conversation Worth Having Now

For VC partners watching a portfolio company struggle to convert pilots into scale, the question isn’t whether EHR integration matters. The question is whether it’s being solved early enough to protect growth.

Connect with Arrowhealth to learn how EHR enablement can strengthen your portfolio companies and your investment thesis.